You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Raw chart and full-history price indicators begin at the captured split on May 20, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on May 20, 2026.
Optimi Health Corp. established Optimi Australia Pty Ltd as a wholly owned distribution and business development subsidiary in Australia and appointed Adrian Jones as Director of Australian Operations.
Optimi Health Corp. completed an MDMA production batch for a proposed Canadian Phase 3 PTSD trial enrolling up to 100 participants, a MAPS Israel trial, and an Australian commercial export planned before the end of 2026; the Canadian trial is expected to begin in 2027.
Optimi Health Corp. will participate in the ThinkEquity Conference on October 15, 2026, at the Mandarin Oriental Hotel in New York City, presenting a corporate overview at 4:00 p.m. Eastern time and holding investor meetings.
* Q4 derived as the full year minus Q1 to Q3.
Illustrative technical + ownership context — a signal mix, not investment advice.
Raw-price comparisons begin at the captured split on May 20, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XCNQ:OPTI | -9.2% | -43.5% | — | -9.2% | — |
Company with tickers: OPTH
Share classes and depositary receipts can have different prices and dividends.
Follow OPTI during the session: the latest price, the day's change, range and volume. Closing prices stay free.
No verified dividend payments are available for this listing yet.
No upcoming investor events are listed for this company yet.
No earnings calls have been captured for this company yet.
